nodes	percent_of_prediction	percent_of_DWPC	metapath
Mecamylamine—Fibrosis—Paclitaxel—ovarian cancer	0.0571	0.0571	CcSEcCtD
Mecamylamine—Dizziness postural—Paclitaxel—ovarian cancer	0.0467	0.0467	CcSEcCtD
Mecamylamine—Ileus—Vinorelbine—ovarian cancer	0.0343	0.0343	CcSEcCtD
Mecamylamine—Convulsion—Altretamine—ovarian cancer	0.0339	0.0339	CcSEcCtD
Mecamylamine—Anorexia—Altretamine—ovarian cancer	0.0305	0.0305	CcSEcCtD
Mecamylamine—Decreased appetite—Altretamine—ovarian cancer	0.0278	0.0278	CcSEcCtD
Mecamylamine—Fatigue—Altretamine—ovarian cancer	0.0276	0.0276	CcSEcCtD
Mecamylamine—Ileus—Paclitaxel—ovarian cancer	0.0231	0.0231	CcSEcCtD
Mecamylamine—Asthenia—Altretamine—ovarian cancer	0.0229	0.0229	CcSEcCtD
Mecamylamine—Pulmonary oedema—Vinorelbine—ovarian cancer	0.0216	0.0216	CcSEcCtD
Mecamylamine—Dizziness—Altretamine—ovarian cancer	0.0211	0.0211	CcSEcCtD
Mecamylamine—Vomiting—Altretamine—ovarian cancer	0.0203	0.0203	CcSEcCtD
Mecamylamine—Ileus—Docetaxel—ovarian cancer	0.0195	0.0195	CcSEcCtD
Mecamylamine—Nausea—Altretamine—ovarian cancer	0.019	0.019	CcSEcCtD
Mecamylamine—Ileus—Epirubicin—ovarian cancer	0.0132	0.0132	CcSEcCtD
Mecamylamine—Tremor—Chlorambucil—ovarian cancer	0.013	0.013	CcSEcCtD
Mecamylamine—Pulmonary oedema—Docetaxel—ovarian cancer	0.0123	0.0123	CcSEcCtD
Mecamylamine—Ileus—Doxorubicin—ovarian cancer	0.0122	0.0122	CcSEcCtD
Mecamylamine—Convulsion—Chlorambucil—ovarian cancer	0.0121	0.0121	CcSEcCtD
Mecamylamine—Anorexia—Chlorambucil—ovarian cancer	0.0108	0.0108	CcSEcCtD
Mecamylamine—Orthostatic hypotension—Paclitaxel—ovarian cancer	0.0108	0.0108	CcSEcCtD
Mecamylamine—Convulsion—Melphalan—ovarian cancer	0.0105	0.0105	CcSEcCtD
Mecamylamine—Glossitis—Epirubicin—ovarian cancer	0.0101	0.0101	CcSEcCtD
Mecamylamine—Decreased appetite—Chlorambucil—ovarian cancer	0.00988	0.00988	CcSEcCtD
Mecamylamine—Fatigue—Chlorambucil—ovarian cancer	0.0098	0.0098	CcSEcCtD
Mecamylamine—Anorexia—Topotecan—ovarian cancer	0.00964	0.00964	CcSEcCtD
Mecamylamine—Anorexia—Melphalan—ovarian cancer	0.00944	0.00944	CcSEcCtD
Mecamylamine—Glossitis—Doxorubicin—ovarian cancer	0.00937	0.00937	CcSEcCtD
Mecamylamine—Orthostatic hypotension—Docetaxel—ovarian cancer	0.00917	0.00917	CcSEcCtD
Mecamylamine—Paraesthesia—Topotecan—ovarian cancer	0.00909	0.00909	CcSEcCtD
Mecamylamine—Paraesthesia—Melphalan—ovarian cancer	0.0089	0.0089	CcSEcCtD
Mecamylamine—Decreased appetite—Topotecan—ovarian cancer	0.0088	0.0088	CcSEcCtD
Mecamylamine—Fatigue—Topotecan—ovarian cancer	0.00872	0.00872	CcSEcCtD
Mecamylamine—Constipation—Topotecan—ovarian cancer	0.00865	0.00865	CcSEcCtD
Mecamylamine—Decreased appetite—Melphalan—ovarian cancer	0.00861	0.00861	CcSEcCtD
Mecamylamine—Fatigue—Melphalan—ovarian cancer	0.00854	0.00854	CcSEcCtD
Mecamylamine—Pulmonary oedema—Epirubicin—ovarian cancer	0.0083	0.0083	CcSEcCtD
Mecamylamine—Anorexia—Vinorelbine—ovarian cancer	0.00825	0.00825	CcSEcCtD
Mecamylamine—Asthenia—Chlorambucil—ovarian cancer	0.00815	0.00815	CcSEcCtD
Mecamylamine—Paraesthesia—Vinorelbine—ovarian cancer	0.00777	0.00777	CcSEcCtD
Mecamylamine—Pulmonary oedema—Doxorubicin—ovarian cancer	0.00768	0.00768	CcSEcCtD
Mecamylamine—Decreased appetite—Vinorelbine—ovarian cancer	0.00752	0.00752	CcSEcCtD
Mecamylamine—Fatigue—Vinorelbine—ovarian cancer	0.00746	0.00746	CcSEcCtD
Mecamylamine—Constipation—Vinorelbine—ovarian cancer	0.0074	0.0074	CcSEcCtD
Mecamylamine—Asthenia—Topotecan—ovarian cancer	0.00726	0.00726	CcSEcCtD
Mecamylamine—Vomiting—Chlorambucil—ovarian cancer	0.00723	0.00723	CcSEcCtD
Mecamylamine—Asthenia—Melphalan—ovarian cancer	0.00711	0.00711	CcSEcCtD
Mecamylamine—Nausea—Chlorambucil—ovarian cancer	0.00675	0.00675	CcSEcCtD
Mecamylamine—Vision blurred—Paclitaxel—ovarian cancer	0.00672	0.00672	CcSEcCtD
Mecamylamine—Dizziness—Topotecan—ovarian cancer	0.00669	0.00669	CcSEcCtD
Mecamylamine—Tremor—Paclitaxel—ovarian cancer	0.00668	0.00668	CcSEcCtD
Mecamylamine—Vomiting—Topotecan—ovarian cancer	0.00643	0.00643	CcSEcCtD
Mecamylamine—Syncope—Paclitaxel—ovarian cancer	0.0064	0.0064	CcSEcCtD
Mecamylamine—Vomiting—Melphalan—ovarian cancer	0.0063	0.0063	CcSEcCtD
Mecamylamine—Loss of consciousness—Paclitaxel—ovarian cancer	0.00627	0.00627	CcSEcCtD
Mecamylamine—Asthenia—Vinorelbine—ovarian cancer	0.00621	0.00621	CcSEcCtD
Mecamylamine—Orthostatic hypotension—Epirubicin—ovarian cancer	0.00618	0.00618	CcSEcCtD
Mecamylamine—Convulsion—Paclitaxel—ovarian cancer	0.00618	0.00618	CcSEcCtD
Mecamylamine—Nausea—Topotecan—ovarian cancer	0.00601	0.00601	CcSEcCtD
Mecamylamine—Nausea—Melphalan—ovarian cancer	0.00588	0.00588	CcSEcCtD
Mecamylamine—Shock—Paclitaxel—ovarian cancer	0.00573	0.00573	CcSEcCtD
Mecamylamine—Dizziness—Vinorelbine—ovarian cancer	0.00572	0.00572	CcSEcCtD
Mecamylamine—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.00572	0.00572	CcSEcCtD
Mecamylamine—Anorexia—Paclitaxel—ovarian cancer	0.00555	0.00555	CcSEcCtD
Mecamylamine—Vomiting—Vinorelbine—ovarian cancer	0.0055	0.0055	CcSEcCtD
Mecamylamine—Syncope—Docetaxel—ovarian cancer	0.00542	0.00542	CcSEcCtD
Mecamylamine—Loss of consciousness—Docetaxel—ovarian cancer	0.00531	0.00531	CcSEcCtD
Mecamylamine—Convulsion—Docetaxel—ovarian cancer	0.00524	0.00524	CcSEcCtD
Mecamylamine—Paraesthesia—Paclitaxel—ovarian cancer	0.00523	0.00523	CcSEcCtD
Mecamylamine—Nausea—Vinorelbine—ovarian cancer	0.00514	0.00514	CcSEcCtD
Mecamylamine—Decreased appetite—Paclitaxel—ovarian cancer	0.00506	0.00506	CcSEcCtD
Mecamylamine—Fatigue—Paclitaxel—ovarian cancer	0.00502	0.00502	CcSEcCtD
Mecamylamine—Constipation—Paclitaxel—ovarian cancer	0.00498	0.00498	CcSEcCtD
Mecamylamine—Shock—Docetaxel—ovarian cancer	0.00485	0.00485	CcSEcCtD
Mecamylamine—Anorexia—Docetaxel—ovarian cancer	0.0047	0.0047	CcSEcCtD
Mecamylamine—Paraesthesia—Docetaxel—ovarian cancer	0.00443	0.00443	CcSEcCtD
Mecamylamine—Decreased appetite—Docetaxel—ovarian cancer	0.00429	0.00429	CcSEcCtD
Mecamylamine—Fatigue—Docetaxel—ovarian cancer	0.00425	0.00425	CcSEcCtD
Mecamylamine—Constipation—Docetaxel—ovarian cancer	0.00422	0.00422	CcSEcCtD
Mecamylamine—Asthenia—Paclitaxel—ovarian cancer	0.00418	0.00418	CcSEcCtD
Mecamylamine—Dizziness—Paclitaxel—ovarian cancer	0.00385	0.00385	CcSEcCtD
Mecamylamine—Vision blurred—Epirubicin—ovarian cancer	0.00384	0.00384	CcSEcCtD
Mecamylamine—Vomiting—Paclitaxel—ovarian cancer	0.0037	0.0037	CcSEcCtD
Mecamylamine—Syncope—Epirubicin—ovarian cancer	0.00366	0.00366	CcSEcCtD
Mecamylamine—Loss of consciousness—Epirubicin—ovarian cancer	0.00358	0.00358	CcSEcCtD
Mecamylamine—Vision blurred—Doxorubicin—ovarian cancer	0.00356	0.00356	CcSEcCtD
Mecamylamine—Asthenia—Docetaxel—ovarian cancer	0.00354	0.00354	CcSEcCtD
Mecamylamine—Convulsion—Epirubicin—ovarian cancer	0.00353	0.00353	CcSEcCtD
Mecamylamine—Nausea—Paclitaxel—ovarian cancer	0.00346	0.00346	CcSEcCtD
Mecamylamine—Syncope—Doxorubicin—ovarian cancer	0.00338	0.00338	CcSEcCtD
Mecamylamine—Loss of consciousness—Doxorubicin—ovarian cancer	0.00332	0.00332	CcSEcCtD
Mecamylamine—Shock—Epirubicin—ovarian cancer	0.00327	0.00327	CcSEcCtD
Mecamylamine—Convulsion—Doxorubicin—ovarian cancer	0.00327	0.00327	CcSEcCtD
Mecamylamine—Dizziness—Docetaxel—ovarian cancer	0.00326	0.00326	CcSEcCtD
Mecamylamine—Anorexia—Epirubicin—ovarian cancer	0.00317	0.00317	CcSEcCtD
Mecamylamine—Vomiting—Docetaxel—ovarian cancer	0.00314	0.00314	CcSEcCtD
Mecamylamine—Shock—Doxorubicin—ovarian cancer	0.00303	0.00303	CcSEcCtD
Mecamylamine—Paraesthesia—Epirubicin—ovarian cancer	0.00299	0.00299	CcSEcCtD
Mecamylamine—Anorexia—Doxorubicin—ovarian cancer	0.00294	0.00294	CcSEcCtD
Mecamylamine—Nausea—Docetaxel—ovarian cancer	0.00293	0.00293	CcSEcCtD
Mecamylamine—Decreased appetite—Epirubicin—ovarian cancer	0.00289	0.00289	CcSEcCtD
Mecamylamine—Fatigue—Epirubicin—ovarian cancer	0.00287	0.00287	CcSEcCtD
Mecamylamine—Constipation—Epirubicin—ovarian cancer	0.00285	0.00285	CcSEcCtD
Mecamylamine—Paraesthesia—Doxorubicin—ovarian cancer	0.00277	0.00277	CcSEcCtD
Mecamylamine—Decreased appetite—Doxorubicin—ovarian cancer	0.00268	0.00268	CcSEcCtD
Mecamylamine—Fatigue—Doxorubicin—ovarian cancer	0.00266	0.00266	CcSEcCtD
Mecamylamine—Constipation—Doxorubicin—ovarian cancer	0.00263	0.00263	CcSEcCtD
Mecamylamine—Asthenia—Epirubicin—ovarian cancer	0.00239	0.00239	CcSEcCtD
Mecamylamine—Asthenia—Doxorubicin—ovarian cancer	0.00221	0.00221	CcSEcCtD
Mecamylamine—Dizziness—Epirubicin—ovarian cancer	0.0022	0.0022	CcSEcCtD
Mecamylamine—Vomiting—Epirubicin—ovarian cancer	0.00212	0.00212	CcSEcCtD
Mecamylamine—Dizziness—Doxorubicin—ovarian cancer	0.00204	0.00204	CcSEcCtD
Mecamylamine—Nausea—Epirubicin—ovarian cancer	0.00198	0.00198	CcSEcCtD
Mecamylamine—Vomiting—Doxorubicin—ovarian cancer	0.00196	0.00196	CcSEcCtD
Mecamylamine—Nausea—Doxorubicin—ovarian cancer	0.00183	0.00183	CcSEcCtD
